Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours

British Journal of Cancer

Volumn 73, Issue 5, 1996, Pages 624-629

  Yamada, N ^a   Kato, M ^a   Ten Dijke, P ^a   Yamashita, H ^a   Sampath, T K ^b   Heldin, C H ^a   Miyazono, K ^a   Funa, K ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b CURIS INC   (United States)

Author keywords

Activin type I receptor; Bone morphogenetic protein; Bone morphogenetic protein type I receptor; Immunohistochemistry

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; CELL RECEPTOR; OSTEOGENIC PROTEIN 1;

ARTICLE; ASTROCYTOMA; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVOUS TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR CELL;

EID: 0030052362     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.108     Document Type: Article

References (44)

1. BASLER K, EDLUND T, JESSEL TM AND YAMADA T. (1993). Control of cell pattern in the neural tube: regulation of cell differentiation by dorsalin-1, a novel TGFβ family member. Cell. 73, 687-702.
2. CELESTE AJ, IANNAZZI JA, TAYLOR RC HEWICK RM, ROSEN V, WANG EA AND WOZNEY JM. (1990). Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc. Natl Acad. Sci. USA, 87, 9843-9847.
3. COLLINS UP AND JAMES CD. (1993). Genes and chromosomal alterations associated with the development of human gliomas. FASEB J., 7, 926-930.
4. CUNNINGHAM NS, PARALKAR V AND REDDI AH. (1992). Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor β1 mRNA expression. Proc. Natl Acad. Sci. USA, 89, 11740-11744.
5. DEWULF N, VERSCHUEREN K, LONNOY O, MORÉN A. GRIMSBY S, SPIEGLE KV, MIYAZONO K, HUYLEBROECK D AND TEN DIJKE P. (1995). Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology, 136, 2652-2663.
6. HERMANSON M, FUNA K, HARTMAN M, CLAESSON-WELSH L, HELDIN C-H, WESTERMARK B AND NISTÉR. (1992). Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of aulocrine and puracrine loops. Cancer Res., 52, 3213-3219.
7. KINGSLEY DM. (1994a). What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet., 10, 16-21.
8. KINGSLEY DM. (1994b). The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev., 8, 133-146.
9. KLEIHUES P, BURGER PC AND SCHEITHAUER BW. (1993). Histological typing of tumours of the central nervous system. In International Histological Classification of Tumours. World Health Organization: Geneva.
10. LEE S-J. (1991). Expression of growth/differentiation factor 1 in the nervous system: Conservation of bicistronic structure. Proc. Natl Acad. Sci. USA, 88, 4250-4254.
11. LIBERMANN TA, NUSBAUM HR, RAZON N, KRIS R, LAX I, SOREQ H, WHITTLE N, WATERFIELD MD, ULLRICH A AND SCHLESSINGER J. (1985). Amplification, enhanced expression and possible rearrangement of EGF-receptor gene in primary human brain tumours of glioma origin. Nature, 313, 144-147.
12. LYONS KM, JONES CM AND HOGAN BLM. (1991). The DVR gene family in embryonic development. Trends Genet., 7, 408-412.
13. MASSAGUÉ J, ATTISANO L AND WRANA JL. (1994). The TGF-β family and its composite receptors. Trends Cell Biol., 4, 172-178.
14. MCCARTHY SA AND BICKNELL R. (1993). Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem., 268, 23066-23071.
15. MATHEWS LS AND VALE WW. (1991). Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell, 65, 975-982.
16. MATZUK MM, FINEGOLD MJ, SU J-GJ, HSUEH AJW AND BRADLEY A. (1992). α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature, 360, 313-319.
17. NIGRO JM, BAKER SJ, PREISINGER AC, JESSUP JM, HOSTETTER R, CLEARY K, BIGNER SH, DAVIDSON N, BAYLIN S, DEVILLE P, GLOVER T, COLLINS FS, WESTON A, MODALI R, HARRIS CC AND VOGELSTEIN B. (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
18. NISTÉR M, CLAESSON-WELSH L, ERIKSSON A, HELDIN C-H AND WESTERMARK B. (1991). Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol. Chem., 266, 16755-16763.
19. ÖZKAYNAK E, RUEGER DC, DRIER EA, CORBETT C, RIDGE RJ, SAMPATH TK AND OPPERMANN H. (1990). OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J., 9, 2085 2093.
20. ÖZKAYNAK K, SCHNEGELSBERG PNJ, JIN DF, CLIFFORD GM, WARREN FD, DRIER EA AND OPPERMANN H. (1992). Osteogenic protein-2: a new member of the transforming growth factor-β superfamily expressed early in embryogenesis. J. Biol. Chem., 267, 25220-25227.
21. PARALKAR VM, WEEKS BS, YU YM, KLEINMAN HK AND REDDI AH. (1992). Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. J. Cell Biol., 119, 1721-1728.
22. PERIDES G, SAFRAN RM, RUEGER DC AND CHARNESS ME. (1992). Induction of the neural cell adhesion molecule and neuronal aggregation by osteogenic protein 1. Proc. Natl Acad. Sci. USA, 89, 10326-10330.
23. PERIDES G, HU G, RUEGER DC AND CHARNESS ME. (1993). Osteogenic protein-1 regulates L1 and neural cell adhesion molecule gene expression in neural cells. J. Biol. Chem., 268, 25197-25205.
24. REDDI AH. (1992). Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr. Opin. Cell Biol., 4, 850-855.
25. ROZENZWEIG BL, IMAMURA T, OKADOME T, COX GN, YAMASHITA H, TEN DIJKE P, HELDIN C-H AND MIYAZONO K. (1995). Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl Acad. Sci. USA, 92, 7632-7636.
26. SAMPATH TK, MALIAKAL JC, HAUSCHKA PV, JONES WK, SASAK HM, TUCKER RF, WHITE KH, COUGHLIN JE, TUCKER MM, PANG RH, CORBETT C, ÖZKAYNAK E, OPPERMANN H AND RUEGER DC. (1992). Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vivo. J. Biol. Chem., 267, 20352-20362.
27. STORM EE, HUYNH TV, COPELAND NG, JENKINS NA, KINGSLEY DM AND LEE S-J. (1994). Limb alterations in Brachypodism mice due to mutations in a new member of the TGFβ superfamily. Nature, 368, 639-643.
28. TEN DIJKE P, ICHIJO H, FRANZÉN P, SCHULZ P, SARAS J, TOYOSHIMA H, HELDIN C-H, AND MIYAZONO K. (1993). Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine threonine kinase activity. Oncogene, 8, 2879-2887.
29. TEN DIJKE P, FRANZÉN P, YAMASHITA H, ICHIJO H, HELDIN C-H AND MIYAZONO K. (1994a). Serine/threonine kinase receptors. Prog. Growth Factor Res., 6, 55-72.
30. TEN DIJKE P, YAMASHITA H, SAMPATH TK, REDDI AH, ESTEVEZ M, RIDDLE DL, ICHIJO H, HELDIN C-H AND MIYAZONO K. (1994b). Characterization of type I receptors for transforming growth factor-β and activin. Science, 264, 101-104.
31. TEN DIJKE P, YAMASHITA H, ICHIJO H, FRANZÉN P, LAIHO M, MIYAZONO K AND HELDIN C-H. (1994c). Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem., 269, 16985-16988.
32. VENTER DJ, BEVAN KL, LUDWIG RL, RILEY TE, JAT PS, THOMAS DG AND NOBLE MD. (1991). Retinoblastoma gene deletions in human glioblastomas. Oncogene, 6, 445-448.
33. VERSCHUEREN K, DEWULF N, GOUMANS M-J, LONNOY O, FEIJEN A, GRIMSBY S, VANDE SPIEGLE K, TEN DIJKE P, MORÉN A, VANSCHEEUWIJCK P, HELDIN C-H, MIYAZONO K, MUMMERY C, VAN DEN EIJNDEN-VAN RAAIJ J AND HUYLEB-ROECK D. (1995). Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mech. of Dev., 52, 109-123.
34. VUKICEVIC S, LUYTEN FP AND REDDI AH. (1989). Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc. Natl Acad. Sci. USA. 86, 8793-8797.
35. VUKICEVIC S, LATIN V, CHEN P, BATORSKY R, REDDI AH AND SAMPATH TK. (1994). Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membrane. Biochem. Biophys. Res. Commun., 198, 693-700.
36. WALLEN JW, CATE RL, KIEFER DM, RIEMEN MW, MARTINEZ D, HOFFMAN RM, DONAHOE PK, VON HOFF DD, PEPINSKY B AND OLIFF A. (1989). Minimal antiproliferative effect of recombinant Mullerian inhibiting substance on gynecological tumour cell lines and tumour explants. Cancer Res., 49, 2005-2011.
37. WALTENBERGER J, LUNDIN L, ÖBERG K, WILANDER E, MIYAZONO K, HELDIN C-H AND FUNA K. (1993a). Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am. J. Pathol., 142, 71-78.
38. WALTENBERGER J, WANDERS A, FELLSTRÖM B, MIYAZONO K, HELDIN C-H AND FUNA K. (1993b). Induction of transforming growth factor-β during cardiac allograft rejection. J. Immunol., 151, 1147-1157.
39. WONG AJ, BIGNER SH, BIGNER DD, KINZLER KW, HAMILTON SR AND VOGELSTEIN B. (1987). Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl Acad. Sci. USA, 84, 6899-6903.
40. WOZNEY JM. (1989). Bone morphogenetic proteins. Prog. Growth Factor Res., 1, 267-280.
41. WOZNEY JM, ROSEN V, CELESTE AJ, MITSOCK LM, WHITTERS MJ, KRIZ RW, HEWICK RM AND WANG EA. (1988). Novel regulators of bone formation: molecular clones and activities. Science, 242, 1528-1534.
42. WRANA JL, ATTISANO L, WIESER R, VENTURA F AND MASSAGUÉ J. (1994). Mechanism of activation of the TGF-β receptor. Nature, 370, 341-347.
43. YAMADA N, KATO M, YAMASHITA H, NISTÉR M, MIYAZONO K, HELDIN C-H AND FUNA K. (1995). Enhanced expression of transforming growth factor-β and its type I and type II receptors in human glioblastoma multiforme. Int. J. Cancer, 62, 1-7.
44. YAMASHITA H, TEN DIJKE P, HUYLEBROECK D, SAMPATH TK, ANDRIES M, SMITH JC, HELDIN C-H AND MIYAZONO K. (1995). Osteogenic protein-1 binds to activin type II receptor and induces certain activin-like effects. J. Cell Biol., 130, 217-226.